Fundraising Fox
predictXbio
Founded 2023 · 1 employees on LinkedIn · 1 known investors
Find your way into predictXbio
Sign up to see every warm intro you have to predictXbio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the predictXbio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
PredictXBio uses AI, machine learning, and bioinformatics pipelines to predict how pathogens respond to drugs and to model antimicrobial potency in silico, aiming to accelerate discovery of antimicrobials against antimicrobial resistance. Its tools serve drug developers by predicting future resistance mutations and testing therapeutic compounds computationally.
Founders & leadership
predictXbio was founded in 2023 by Cory Kromer-Edwards.
CK
Cory Kromer-EdwardsFounder/CEOCory Kromer-Edwards is the founder and CEO of PredictXBio, which develops machine learning and bioinformatics tools to predict pathogen drug resistance and model antimicrobial potency.
RD
Russ DondaChief Strategy OfficerRuss Donda has spent over 25 years working across innovation strategy, intellectual property, and commercialization, with experience across multiple ventures that raised over $500M and completed exits through public offerings and acquisitions. He currently serves as Chief Strategy Officer at PredictXBio, which uses machine learning and bioinformatics to accelerate antimicrobial drug discovery.
Investors · 1
Frequently asked questions
- What does predictXbio do?
- PredictXBio uses AI, machine learning, and bioinformatics pipelines to predict how pathogens respond to drugs and to model antimicrobial potency in silico, aiming to accelerate discovery of antimicrobials against antimicrobial resistance. Its tools serve drug developers by predicting future resistance mutations and testing therapeutic compounds computationally.
- Who founded predictXbio?
- predictXbio was founded by Cory Kromer-Edwards in 2023.
- Who are predictXbio's investors?
- predictXbio's investors include JumpStart Equity.